arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

CUMBERLAND PHARMACEUTICALS INC

CPIX

$4.99 ▲ +0.54 (+12.26%) at close

18 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

CUMBERLAND PHARMACEUTICALS INC faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $74.1M

Dividend Yield —

Revenue Growth 17.6% ↗

Op. Margin -6.3% ↗

ROIC -8.9% ↗

FCF / Share $0.33 ↗

Trailing P/E —

Price / Book 3.0x

FCF Yield 6.5%

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$44.52M

↑ +17.6% —

Net Income Profit after all expenses

$-2.84M

↑ +56.2% —

Operating Margin Operating profit as % of sales

-6.3%

↑ +63.1% 19th

FCF / Share Free cash flow per share

$0.33

↑ +774.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Financial Health ↑

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	17.6% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+120%)	-4.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-153%)	-5.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-173%)	16.7% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+109%)	-3.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-149%)	8.9% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11%)	-15.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-295%)	-1.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-112%)	1957.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+24369%)	122.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1428%)	50.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+525%)	-25.0% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-412%)	-98.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1330%)	-4.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-156%)	11.5% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+43%)	5.4% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-33%)	—	—
EPS Growth YoY (%)	58.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-4.5% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-15.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-58.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-9.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	4.3% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	48.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	10.0% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-733.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	-71.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	7.1% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	133.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-45.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	56.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-3.2% Weak ↑ Weak Improving Year-over-year change in net income	-12.7% Weak ↑ Weak Improving Year-over-year change in net income	-58.8% Weak ↓ Weak Declining Year-over-year change in net income	-5.0% Weak ↓ Weak Declining Year-over-year change in net income	5.6% Fair ↑ Fair Improving Year-over-year change in net income	49.2% Excellent ↑ Excellent Improving Year-over-year change in net income	12.7% Fair ↑ Fair Improving Year-over-year change in net income	-744.6% Weak Weak Year-over-year change in net income	N/M	-69.8% Weak Weak Year-over-year change in net income	N/M	N/M	3.3% Caution ↓ Caution Declining Year-over-year change in net income	130.3% Excellent Excellent Year-over-year change in net income	-20.5% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	N/M	-29.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	37.0% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	20.3% Good ↓ Good Declining Year-over-year change in free cash flow	90.6% Excellent Excellent Year-over-year change in free cash flow	7.3% Fair Fair Year-over-year change in free cash flow	N/M	N/M	-92.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	-7.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	947.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-89.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	-18.1% Weak Weak Year-over-year change in free cash flow	N/M	18.2% Good Good Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	2.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	1.7% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	1.8% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	6.9% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	-4.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-3.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	158.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	256.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	309.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	35.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-73.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-77.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-74.1% Weak Weak Compound annual revenue growth over 3 years	3.9% Caution Caution Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	3.5% Caution ↑ Caution Improving Compound annual revenue growth over 5 years	1.9% Caution ↓ Caution Declining Compound annual revenue growth over 5 years	-0.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	0.4% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	78.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	110.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	124.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	119.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-3.4% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-47.7% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-54.4% Weak Weak Compound annual revenue growth over 5 years	-57.6% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	-48.9% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-20.6% Weak Weak Compound annual EPS growth over 3 years	—	10.9% Good Good Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	-6.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-142%)	-17.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-213%)	-24.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-261%)	-13.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-191%)	-21.3% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-242%)	-17.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-214%)	-27.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-280%)	-18.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-221%)	-9.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-166%)	-71.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-578%)	—	—	-475.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3268%)	18.1% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+20%)	19.3% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+28%)	14.2% Fair Fair Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-6%)	13.3% Fair Fair Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-12%)	—
Effective Tax Rate (%) (%)	—	0.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-6.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-153%)	-17.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-243%)	-15.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-232%)	-13.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-210%)	-9.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-181%)	-8.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-174%)	-10.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-186%)	-17.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-242%)	-19.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-262%)	-47.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-494%)	81.3% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+577%)	—	-263.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2292%)	12.0% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	11.1% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-8%)	5.4% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-55%)	7.1% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-41%)	—
FCF Margin (%) (%)	10.9% Fair → Fair Stable Free cash flow as a percentage of revenue Optimal: > 10%	-1.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	14.7% Fair ↓ Fair Declining Free cash flow as a percentage of revenue Optimal: > 10%	19.9% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	17.3% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	14.1% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	8.2% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	6.5% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	-2.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	21.9% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	81.1% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	13.7% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	16.6% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	-0.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-0.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	-1.70x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.93x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-1.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-1.78x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-1.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.79x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.38x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.46x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	7.84x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	2.69x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.31x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.50x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-0.09x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.06x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	-8.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-32.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-18.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	8.1% Fair → Fair Stable Return earned on debt + equity capital invested Optimal: > 10%	9.4% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	6.6% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-3.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-8.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-1.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	1.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	3.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	8.9% Fair → Fair Stable Operating profit relative to total assets Optimal: > 10%	10.3% Good Good Operating profit relative to total assets Optimal: > 10%	7.1% Fair Fair Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-11.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-28.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-289%)	-21.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	-15.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-202%)	-8.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-7.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-6.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-12.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-12.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-1.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-109%)	1.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-94%)	3.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-80%)	-2.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-118%)	6.8% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-55%)	6.8% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-55%)	3.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-79%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Interest Coverage (x)	-5.63x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.62x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-14.31x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.74x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-78.32x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-24.21x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-37.73x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-37.74x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-43.93x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.47x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	15.05x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	53.06x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-36.76x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	122.50x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	27.86x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	4.57x Fair Fair Operating income divided by interest expense Optimal: > 5x	7.47x Good Good Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-11.44M	$-17.96M	$-18.32M	$-19.76M	$-27.04M	$-24.75M	$-28.21M	$-27.94M	$-45.41M	$-34.51M	$-38.20M	$-39.87M	$-40.87M	$-54.35M	$-70.60M	$-65.89M	$-78.70M	$-11.83M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$3.00	$2.69	$2.77	$2.88	$2.41	$2.47	$2.23	$2.61	$2.59	$0.12	$0.05	$0.03	$0.04	$2.50	$2.51	$2.26	$3.07	—
Basic EPS, GAAP (USD)	$-0.19	$-0.46	$-0.44	$-0.38	$-0.24	$-0.22	$-0.23	$-0.45	$-0.50	$-0.06	$0.04	$0.14	$-0.11	$0.30	$0.28	$0.12	$0.22	—
Free Cash Flow per Share (USD)	$0.33	$-0.05	$0.41	$0.57	$0.42	$0.35	$0.18	$0.17	$-0.05	$0.03	$0.34	$0.37	$0.04	$0.34	$0.42	$-0.01	$-0.01	—
Book Value per Share (USD)	$1.66	$1.64	$2.10	$2.52	$2.90	$3.14	$3.35	$3.61	$3.99	$4.56	$4.69	$4.72	$4.42	$4.53	$4.08	$3.82	—	—
Tangible Book Value per Share (USD)	$1.60	$1.57	$2.03	$2.46	$2.84	$3.08	$3.29	$3.56	$3.99	$4.56	$4.69	$4.72	$4.42	$4.53	$4.08	$3.82	—	—
Basic Weighted Avg Shares (shares)	14.85M	14.06M	14.30M	14.56M	14.90M	15.16M	15.40M	15.61M	15.91M	16.24M	16.72M	17.62M	18.33M	19.56M	20.34M	20.33M	14.20M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$315.35K	$4.83M	$7.73M	$17.29M	$26.41M	$24.30M	$26.01M	$31.31M	$50.99M	$50.75M	$52.17M	$57.07M	$61.13M	$79.18M	$80.71M	$71.81M	—	—
Total Equity (USD)	$24.88M	$22.85M	$29.60M	$36.27M	$42.81M	$46.99M	$51.12M	$55.84M	$64.12M	$73.25M	$76.89M	$80.76M	$79.47M	$85.70M	$82.93M	$77.78M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$44.52M	$37.87M	$39.55M	$42.01M	$35.99M	$37.44M	$34.39M	$40.74M	$41.15M	$2.00M	$900.00K	$600.00K	$800.00K	$48.85M	$51.14M	$45.88M	$43.54M	—
Depreciation Expense (USD)	$4.15M	$4.90M	$4.94M	$5.33M	$4.61M	$4.75M	$4.40M	$2.98M	$2.65M	$2.40M	$2.25M	$1.99M	$1.30M	$901.65K	$1.04M	$978.40K	$816.50K	—
Net Income, GAAP (USD)	$-2.84M	$-6.48M	$-6.28M	$-5.57M	$-3.51M	$-3.34M	$-3.54M	$-6.96M	$-7.98M	$-944.68K	$731.35K	$2.42M	$-2.10M	$5.84M	$5.66M	$2.46M	$3.09M	—
Operating Cash Flow (USD)	$4.93M	$-612.19K	$6.09M	$8.45M	$6.34M	$5.42M	$3.06M	$3.11M	$-557.71K	$569.48K	$5.88M	$6.69M	$746.13K	$7.14M	$8.72M	$346.66K	$404.97K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 68 quarters

CUMBERLAND PHARMACEUTICALS INC

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CPIX with peers